Search results for: Adrian Towse
Filter search results
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
1 March 2019
…Towse, A., Segel C.S., Henshall, C., Pearson, S.D. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates. Institute for Clinical and Economic Review and the…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…Hideo Yasunaga and Hayato Yamana through desk research, using the same pre-specified pro-forma as for the previous reports. 1 Cole,A., Garrison,L., Mestre-Ferrandiz,J., Towse,A., 2015. Data Governance Arrangements for Real-World Evidence.OHE…
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
1 September 2020
…Pearson S, Lowe M, Towse A, Segel C, Henshall C. 2020. Cornerstones of “Fair” Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals. Institute for Clinical and Economic Review…
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
1 February 2021
…decision making. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/international-cost-effectiveness-thresholds-and-modifiers-hta-decision-making Berdud M., Ferraro J., Towse A. 2020. A theory on ICER pricing and optimal level of cost-effectiveness…
Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies
1 June 2021
…place. Acknowledgement: This report was commissioned by Novartis Gene Therapies. Citation Firth I., Schirrmacher H., Hampson G., Towse A. Key considerations for early access schemes for one-time therapies., London: Office…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…containing the full set of recommendations and details of our analysis, click here. Citations Hitch J., Berdud M., Cubi-Molla P., Garau M., Towse A., 2023. Setting the right discount rate…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…in the evaluation of the cost-effectiveness of a vaccination programme: A critical review. Vaccine, 33(32), pp.3788–3794. 10.1016/j.vaccine.2015.06.084. Jönsson, B., Hampson, G., Michaels, J., Towse, A., Von Der Schulenburg, J.-M.G. and…